Tangeretin

Tangeretin is a lipid of Polyketides (PK) class. Tangeretin is associated with abnormalities such as Cardiovascular Diseases, Complex Regional Pain Syndromes, Blood Clot, Hypercholesterolemia and Restenosis. The involved functions are known as Thrombus, Platelet function, Localized desquamation, Platelet Activation and Signal. Tangeretin often locates in Protoplasm, Cytoplasmic Granules, Cytoplasmic matrix, Plasma membrane and Blood. The associated genes with Tangeretin are GP6 gene, CDK2 gene, CDK6 gene, Tumor Suppressor Genes and CDH1 gene. The related lipids are Lipopolysaccharides. The related experimental models are Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Tangeretin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Tangeretin?

Tangeretin is suspected in Complex Regional Pain Syndromes, Cardiovascular Diseases, Blood Clot, Hypercholesterolemia, Restenosis and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Tangeretin

MeSH term MeSH ID Detail
Atherosclerosis D050197 85 associated lipids
Carcinoma, Ductal, Breast D018270 19 associated lipids
Reperfusion Injury D015427 65 associated lipids
Thrombosis D013927 49 associated lipids
Parkinson Disease D010300 53 associated lipids
Neuroblastoma D009447 66 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Lung Neoplasms D008175 171 associated lipids
Insulin Resistance D007333 99 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Per page 10 20 | Total 13

PubChem Associated disorders and diseases

What pathways are associated with Tangeretin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Tangeretin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Tangeretin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Tangeretin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Tangeretin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Tangeretin?

Mouse Model

Mouse Model are used in the study 'Methoxyflavones protect cells against endoplasmic reticulum stress and neurotoxin.' (Takano K et al., 2007) and Mouse Model are used in the study 'Influence of tangeretin on tamoxifen's therapeutic benefit in mammary cancer.' (Bracke ME et al., 1999).

Transgenic Model

Transgenic Model are used in the study 'Methoxylated flavones, a superior cancer chemopreventive flavonoid subclass?' (Walle T, 2007).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Tangeretin

Download all related citations
Per page 10 20 50 100 | Total 222
Authors Title Published Journal PubMed Link
pmid:
Wang MS et al. Inhibition of 11beta-hydroxysteroid dehydrogenase in guinea pig kidney by three bioflavonoids and their interactions with gossypol. 2002 Acta Pharmacol. Sin. pmid:11860745
Guo XQ et al. Tangeretin alters neuronal apoptosis and ameliorates the severity of seizures in experimental epilepsy-induced rats by modulating apoptotic protein expressions, regulating matrix metalloproteinases, and activating the PI3K/Akt cell survival pathway. 2017 Adv Med Sci pmid:28501723
Brack ME et al. The citrus methoxyflavone tangeretin affects human cell-cell interactions. 2002 Adv. Exp. Med. Biol. pmid:12083457
Takano K et al. Methoxyflavones protect cells against endoplasmic reticulum stress and neurotoxin. 2007 Am. J. Physiol., Cell Physiol. pmid:16971492
Yi LZ et al. Quality control and discrimination of pericarpium citri reticulatae and pericarpium citri reticulatae viride based on high-performance liquid chromatographic fingerprints and multivariate statistical analysis. 2007 Anal. Chim. Acta pmid:17386812
Yi LZ et al. Fingerprinting alterations of secondary metabolites of tangerine peels during growth by HPLC-DAD and chemometric methods. 2009 Anal. Chim. Acta pmid:19664461
Tistaert C et al. Quality control of Citri reticulatae pericarpium: exploratory analysis and discrimination. 2011 Anal. Chim. Acta pmid:21962354
Rooprai HK et al. Influence of putative antiinvasive agents on matrix metalloproteinase secretion by human neoplastic glia in vitro. 1999 Ann. N. Y. Acad. Sci. pmid:10415799
Bracke ME et al. Plant polyphenolics as anti-invasive cancer agents. 2008 Anticancer Agents Med Chem pmid:18288920
Kandaswami C et al. Differential inhibition of proliferation of human squamous cell carcinoma, gliosarcoma and embryonic fibroblast-like lung cells in culture by plant flavonoids. 1992 Anticancer Drugs pmid:1450447
Vaiyapuri S et al. Tangeretin regulates platelet function through inhibition of phosphoinositide 3-kinase and cyclic nucleotide signaling. 2013 Arterioscler. Thromb. Vasc. Biol. pmid:24135020
Meiyanto E et al. Natural products for cancer-targeted therapy: citrus flavonoids as potent chemopreventive agents. 2012 Asian Pac. J. Cancer Prev. pmid:22524801
Whitman SC et al. Nobiletin, a citrus flavonoid isolated from tangerines, selectively inhibits class A scavenger receptor-mediated metabolism of acetylated LDL by mouse macrophages. 2005 Atherosclerosis pmid:15585197
Nagase H et al. Nobiletin and its related flavonoids with CRE-dependent transcription-stimulating and neuritegenic activities. 2005 Biochem. Biophys. Res. Commun. pmid:16253614
Quintieri L et al. Flavonoids diosmetin and luteolin inhibit midazolam metabolism by human liver microsomes and recombinant CYP 3A4 and CYP3A5 enzymes. 2008 Biochem. Pharmacol. pmid:18191104
Chen KH et al. Tangeretin suppresses IL-1beta-induced cyclooxygenase (COX)-2 expression through inhibition of p38 MAPK, JNK, and AKT activation in human lung carcinoma cells. 2007 Biochem. Pharmacol. pmid:17067555
Lakshmi A and Subramanian S Chemotherapeutic effect of tangeretin, a polymethoxylated flavone studied in 7, 12-dimethylbenz(a)anthracene induced mammary carcinoma in experimental rats. 2014 Biochimie pmid:24299963
Eguchi A et al. Suppressive effects of demethylated metabolites of nobiletin on phorbol ester-induced expression of scavenger receptor genes in THP-1 human monocytic cells. 2007 Biofactors pmid:18806314
Siess MH et al. Mechanisms involved in the chemoprevention of flavonoids. 2000 Biofactors pmid:11216486
Yamanishi Y et al. Drug-target interaction prediction from chemical, genomic and pharmacological data in an integrated framework. 2010 Bioinformatics pmid:20529913
Yamaguchi M et al. Effects of Cultivation Month and Genetic Background on Phenolic Content of Citrus tachibana Peel. 2018 Biol. Pharm. Bull. pmid:30068877
Choi SY et al. Correlation between flavonoid content and the NO production inhibitory activity of peel extracts from various citrus fruits. 2007 Biol. Pharm. Bull. pmid:17409518
Green CO et al. Determination of polymethoxylated flavones in peels of selected Jamaican and Mexican citrus (Citrus spp.) cultivars by high-performance liquid chromatography. 2007 Biomed. Chromatogr. pmid:17080505
Ma LL et al. Tangeretin induces cell cycle arrest and apoptosis through upregulation of PTEN expression in glioma cells. 2016 Biomed. Pharmacother. pmid:27261630
Chen F et al. Tangeretin inhibits high glucose-induced extracellular matrix accumulation in human glomerular mesangial cells. 2018 Biomed. Pharmacother. pmid:29710524
Akao Y et al. Interactive effects of polymethoxy flavones from Citrus on cell growth inhibition in human neuroblastoma SH-SY5Y cells. 2008 Bioorg. Med. Chem. pmid:18282757
Oshitari T et al. B-Ring-modified and/or 5-demethylated nobiletin congeners: inhibitory activity against pro-MMP-9 production. 2011 Bioorg. Med. Chem. pmid:22047798
Quintin J et al. Synthesis and biological evaluation of a series of tangeretin-derived chalcones. 2009 Bioorg. Med. Chem. Lett. pmid:19013795
Quintin J et al. Semisynthesis and antiproliferative evaluation of a series of 3'-aminoflavones. 2009 Bioorg. Med. Chem. Lett. pmid:19457664
Johnson EJ et al. Prioritizing pharmacokinetic drug interaction precipitants in natural products: application to OATP inhibitors in grapefruit juice. 2017 Biopharm Drug Dispos pmid:28032362
Nishimuta H et al. Inhibitory effects of various beverages on human recombinant sulfotransferase isoforms SULT1A1 and SULT1A3. 2007 Biopharm Drug Dispos pmid:17876860
Kuroda Y et al. Activation of human bitter taste receptors by polymethoxylated flavonoids. 2016 Biosci. Biotechnol. Biochem. pmid:27379685
Androutsopoulos VP et al. Cytochrome P450 CYP1A1: wider roles in cancer progression and prevention. 2009 BMC Cancer pmid:19531241
Kim GS et al. Citrus aurantium flavonoids inhibit adipogenesis through the Akt signaling pathway in 3T3-L1 cells. 2012 BMC Complement Altern Med pmid:22471389
Asami Y et al. Use of silkworms for identification of drug candidates having appropriate pharmacokinetics from plant sources. 2010 BMC Pharmacol. pmid:20537191
Hirano T et al. Citrus flavone tangeretin inhibits leukaemic HL-60 cell growth partially through induction of apoptosis with less cytotoxicity on normal lymphocytes. 1995 Br. J. Cancer pmid:8519648
Cheng Z et al. Tangeretin and its metabolite 4'-hydroxytetramethoxyflavone attenuate EGF-stimulated cell cycle progression in hepatocytes; role of inhibition at the level of mTOR/p70S6K. 2011 Br. J. Pharmacol. pmid:21198542
Honda Y et al. Effects of grapefruit juice and orange juice components on P-glycoprotein- and MRP2-mediated drug efflux. 2004 Br. J. Pharmacol. pmid:15504753
Liu LL et al. Tangeretin has anti-asthmatic effects via regulating PI3K and Notch signaling and modulating Th1/Th2/Th17 cytokine balance in neonatal asthmatic mice. 2017 Braz. J. Med. Biol. Res. pmid:28746467
Li YR et al. Tangeretin derivative, 5-acetyloxy-6,7,8,4'-tetramethoxyflavone induces G2/M arrest, apoptosis and autophagy in human non-small cell lung cancer cells in vitro and in vivo. 2016 Cancer Biol. Ther. pmid:26569090
Ionta M et al. Exogenous Cx43 expression decrease cell proliferation rate in rat hepatocarcinoma cells independently of functional gap junction. 2009 Cancer Cell Int. pmid:19678939
Periyasamy K et al. Antitumor efficacy of tangeretin by targeting the oxidative stress mediated on 7,12-dimethylbenz(a) anthracene-induced proliferative breast cancer in Sprague-Dawley rats. 2015 Cancer Chemother. Pharmacol. pmid:25431347
Ishii K et al. Effects of naturally occurring polymethyoxyflavonoids on cell growth, p-glycoprotein function, cell cycle, and apoptosis of daunorubicin-resistant T lymphoblastoid leukemia cells. 2010 Cancer Invest. pmid:19863351
Chaumontet C et al. Flavonoids (apigenin, tangeretin) counteract tumor promoter-induced inhibition of intercellular communication of rat liver epithelial cells. 1997 Cancer Lett. pmid:9103293
Kandaswami C et al. Antiproliferative effects of citrus flavonoids on a human squamous cell carcinoma in vitro. 1991 Cancer Lett. pmid:1998943
Ikegawa T et al. Inhibition of P-glycoprotein by orange juice components, polymethoxyflavones in adriamycin-resistant human myelogenous leukemia (K562/ADM) cells. 2000 Cancer Lett. pmid:11098080
Morley KL et al. Tangeretin and nobiletin induce G1 cell cycle arrest but not apoptosis in human breast and colon cancer cells. 2007 Cancer Lett. pmid:17197076
Weng CJ and Yen GC Flavonoids, a ubiquitous dietary phenolic subclass, exert extensive in vitro anti-invasive and in vivo anti-metastatic activities. 2012 Cancer Metastasis Rev. pmid:22314287
Arafa el-SA et al. Tangeretin sensitizes cisplatin-resistant human ovarian cancer cells through downregulation of phosphoinositide 3-kinase/Akt signaling pathway. 2009 Cancer Res. pmid:19903849
Chaumontet C et al. Apigenin and tangeretin enhance gap junctional intercellular communication in rat liver epithelial cells. 1994 Carcinogenesis pmid:7955073
Pan MH et al. Tangeretin induces cell-cycle G1 arrest through inhibiting cyclin-dependent kinases 2 and 4 activities as well as elevating Cdk inhibitors p21 and p27 in human colorectal carcinoma cells. 2002 Carcinogenesis pmid:12376477
Wang J et al. Pro-apoptotic effects of the novel tangeretin derivate 5-acetyl-6,7,8,4'-tetramethylnortangeretin on MCF-7 breast cancer cells. 2014 Cell Biochem. Biophys. pmid:24938898
Le Bon AM et al. Inhibition of microsome-mediated binding of benzo[a]pyrene to DNA by flavonoids either in vitro or after dietary administration to rats. 1992 Chem. Biol. Interact. pmid:1643669
Arab HH et al. Tangeretin attenuates cisplatin-induced renal injury in rats: Impact on the inflammatory cascade and oxidative perturbations. 2016 Chem. Biol. Interact. pmid:27616468
Liu L et al. Phytochemical analysis of anti-atherogenic constituents of Xue-Fu-Zhu-Yu-Tang using HPLC-DAD-ESI-MS. 2004 Chem. Pharm. Bull. pmid:15516749
Bracke M et al. Effect of catechins and citrus flavonoids on invasion in vitro. 1991 Jan-Feb Clin. Exp. Metastasis pmid:1901781
Bracke ME et al. The flavonoid tangeretin inhibits invasion of MO4 mouse cells into embryonic chick heart in vitro. 1989 May-Jun Clin. Exp. Metastasis pmid:2924447
Backman JT et al. Lack of correlation between in vitro and in vivo studies on the effects of tangeretin and tangerine juice on midazolam hydroxylation. 2000 Clin. Pharmacol. Ther. pmid:10801247
Braidy N et al. Neuroprotective Effects of Citrus Fruit-Derived Flavonoids, Nobiletin and Tangeretin in Alzheimer's and Parkinson's Disease. 2017 CNS Neurol Disord Drug Targets pmid:28474543
Mareel MM and De Mets M Anti-invasive activities of experimental chemotherapeutic agents. 1989 Crit. Rev. Oncol. Hematol. pmid:2686699
Malemud CJ Inhibitors of stress-activated protein/mitogen-activated protein kinase pathways. 2007 Curr Opin Pharmacol pmid:17398158
Bracke ME et al. The E-cadherin/catenin complex in invasion and metastasis. 1996 Curr. Top. Microbiol. Immunol. pmid:8814984
Mulvihill EE et al. Nobiletin attenuates VLDL overproduction, dyslipidemia, and atherosclerosis in mice with diet-induced insulin resistance. 2011 Diabetes pmid:21471511
Soars MG et al. An assessment of udp-glucuronosyltransferase induction using primary human hepatocytes. 2004 Drug Metab. Dispos. pmid:14709631
Walle UK and Walle T Bioavailable flavonoids: cytochrome P450-mediated metabolism of methoxyflavones. 2007 Drug Metab. Dispos. pmid:17709371
Williams JA et al. Differential modulation of UDP-glucuronosyltransferase 1A1 (UGT1A1)-catalyzed estradiol-3-glucuronidation by the addition of UGT1A1 substrates and other compounds to human liver microsomes. 2002 Drug Metab. Dispos. pmid:12386134
Walsky RL et al. Optimized assays for human UDP-glucuronosyltransferase (UGT) activities: altered alamethicin concentration and utility to screen for UGT inhibitors. 2012 Drug Metab. Dispos. pmid:22357286
Vila-Real H et al. Enzymatic Synthesis of the Flavone Glucosides, Prunin and Isoquercetin, and the Aglycones, Naringenin and Quercetin, with Selective α-L-Rhamnosidase and β-D-Glucosidase Activities of Naringinase. 2011 Enzyme Res pmid:21941631
Hagenlocher Y et al. Citrus peel polymethoxyflavones nobiletin and tangeretin suppress LPS- and IgE-mediated activation of human intestinal mast cells. 2017 Eur J Nutr pmid:27021766
Depypere HT et al. Inhibition of tamoxifen's therapeutic benefit by tangeretin in mammary cancer. 2000 Eur. J. Cancer pmid:11056327
Rong H et al. 8-Prenylnaringenin, the phytoestrogen in hops and beer, upregulates the function of the E-cadherin/catenin complex in human mammary carcinoma cells. 2001 Eur. J. Cell Biol. pmid:11675933
Seo J et al. Tangeretin, a citrus flavonoid, inhibits PGDF-BB-induced proliferation and migration of aortic smooth muscle cells by blocking AKT activation. 2011 Eur. J. Pharmacol. pmid:22040922
Lee DH et al. Flavonoids Isolated from Korea Citrus aurantium L. Induce G2/M Phase Arrest and Apoptosis in Human Gastric Cancer AGS Cells. 2012 Evid Based Complement Alternat Med pmid:22194772
Van Slambrouck S et al. Tangeretin inhibits extracellular-signal-regulated kinase (ERK) phosphorylation. 2005 FEBS Lett. pmid:15757658
Jiang Y et al. Stimulation effect of wide type CFTR chloride channel by the naturally occurring flavonoid tangeretin. 2014 Fitoterapia pmid:25451794
Wan J et al. Enhancement of physical stability and bioaccessibility of tangeretin by soy protein isolate addition. 2017 Food Chem pmid:27979270
Chen J et al. Tangeretin-loaded protein nanoparticles fabricated from zein/β-lactoglobulin: preparation, characterization, and functional performance. 2014 Food Chem pmid:24731371
Han S et al. Simultaneous determination of polymethoxyflavones in Citrus species, Kiyomi tangor and Satsuma mandarin, by high performance liquid chromatography. 2012 Food Chem pmid:23107751
Chen ZT et al. Protective effects of sweet orange (Citrus sinensis) peel and their bioactive compounds on oxidative stress. 2012 Food Chem pmid:22980779
Yang EJ et al. Identification of active compounds from Aurantii Immatri Pericarpium attenuating brain injury in a rat model of ischemia-reperfusion. 2013 Food Chem pmid:23265538
Ho SC and Kuo CT Hesperidin, nobiletin, and tangeretin are collectively responsible for the anti-neuroinflammatory capacity of tangerine peel (Citri reticulatae pericarpium). 2014 Food Chem. Toxicol. pmid:24955543
Stroheker T et al. Steroid activities comparison of natural and food wrap compounds in human breast cancer cell lines. 2004 Food Chem. Toxicol. pmid:15110097
Nielsen SE et al. Biotransformation of the citrus flavone tangeretin in rats. Identification of metabolites with intact flavane nucleus. 2000 Food Chem. Toxicol. pmid:10930694
Kim H et al. Induction of apoptosis in human cervical carcinoma HeLa cells by polymethoxylated flavone-rich Citrus grandis Osbeck (Dangyuja) leaf extract. Food Chem. Toxicol. pmid:20538032
Delaney B et al. Genetic toxicity of a standardized mixture of citrus polymethoxylated flavones. 2002 Food Chem. Toxicol. pmid:11955667
Delaney B et al. Immunotoxicity of a standardized citrus polymethoxylated flavone extract. 2001 Food Chem. Toxicol. pmid:11527568
Su X and D'Souza DH Naturally occurring flavonoids against human norovirus surrogates. 2013 Food Environ Virol pmid:23412728
Fatima A et al. Protective effect of tangeritin in transgenic Drosophila model of Parkinson's disease. 2017 Front Biosci (Elite Ed) pmid:27814588
Hazra B et al. The prospective role of plant products in radiotherapy of cancer: a current overview. 2011 Front Pharmacol pmid:22291649
He YF et al. Tangeritin inhibits adipogenesis by down-regulating C/EBPα, C/EBPβ, and PPARγ expression in 3T3-L1 fat cells. 2015 Genet. Mol. Res. pmid:26535679
Vanhoecke BW et al. A safety study of oral tangeretin and xanthohumol administration to laboratory mice. 2005 Jan-Feb In Vivo pmid:15796161
Walle T Methylation of dietary flavones increases their metabolic stability and chemopreventive effects. 2009 Int J Mol Sci pmid:20087474
Furukawa Y et al. Isolation and characterization of activators of ERK/MAPK from citrus plants. 2012 Int J Mol Sci pmid:22408427
Mazzio EA et al. The biochemical and cellular basis for nutraceutical strategies to attenuate neurodegeneration in Parkinson's disease. 2011 Int J Mol Sci pmid:21340000
Treutter D Managing phenol contents in crop plants by phytochemical farming and breeding-visions and constraints. 2010 Int J Mol Sci pmid:20479987
Jang SE et al. Nobiletin and tangeretin ameliorate scratching behavior in mice by inhibiting the action of histamine and the activation of NF-κB, AP-1 and p38. 2013 Int. Immunopharmacol. pmid:23938254
Shu Z et al. Tangeretin exerts anti-neuroinflammatory effects via NF-κB modulation in lipopolysaccharide-stimulated microglial cells. 2014 Int. Immunopharmacol. pmid:24462494
Kyselova Z Toxicological aspects of the use of phenolic compounds in disease prevention. 2011 Interdiscip Toxicol pmid:22319251
Zeng SL et al. Chemicalome and metabolome profiling of polymethoxylated flavonoids in Citri Reticulatae Pericarpium based on an integrated strategy combining background subtraction and modified mass defect filter in a Microsoft Excel Platform. 2017 J Chromatogr A pmid:28619587